SOHM India receives generic drug formulations purchase order from Sri Lanka
The 10 products range initially within a dosage group of tablets and capsules with other dosage forms to follow. The buyer has placed an initial assorted order for
Biologics contract development and manufacturing organisation (CDMO) AsymBio is set to secure 1.2397bn yuan (approximately $184m) from Asymchem Group, Hillhouse Qirui and other investors to support its long-term growth.
PRIMACYT Cell Culture Technology GmbH provides in-vitro technology services to the pharmaceutical and biotech industry. It currently offers hepatocyte cells to the drug discovery research community throughout Europe.